C4 Therapeutics Statistics
NASDAQ: CCCCHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
2.48+0.04 (+1.64%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
C4 Therapeutics by the numbers
C4 Therapeutics has a market capitalization of $325.7 million based on 131.32M shares outstanding. With trailing EPS of $-0.63, C4 Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 18.2% below its 50-day average and 24.1% below its 200-day average.
Average daily trading volume is 2.57M shares, or about $6.4 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CCCC valuation vs. peer median
| Metric | CCCC | Peer median | Difference |
|---|---|---|---|
| Market cap | $325.67M | $289.71M | +12% |
| Avg. volume | 2.57M | 593.54K | +334% |
Peer median across 8 companies: SLBT, XFOR, TRXB, ALEC, DTIL, AGEN, KYTX, AGMB.
Valuation
- Market cap
- $325.67M
- Price / sales (latest FY)
- 9.06
- EPS (TTM)
- $-0.63
- Shares outstanding
- 131.32M
Price and trading
- Previous close
- 2.44
- Open
- 2.39
- Day range
- 2.32 – 2.55
- 52-week range
- 1.69 – 5.17
- 52-week change
- +1.64%
- Beta
- —
- Volume
- 3.63M
- Average volume
- 2.57M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 325.67M
- Forward Pe
- -3.01
- Eps
- -0.63
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 5.17
- Week52 Low
- 1.69
- Avg Volume
- 2.57M
- Shares Outstanding
- 131.32M
- Ma50
- 3.03
- Ma200
- 3.27
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -52.03%
- Pct From52w Low
- 46.75%